Previous close | 0.4000 |
Open | 0.6000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 60.00 |
Expiry date | 2026-01-16 |
Day's range | 0.4000 - 0.6000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The latest investor updates on stocks that are trending on Wednesday.